AI-assisted, human-published
10/28/2026 /Funding Events
Pathos AI Nets $237M Series E Led by BMS, Valuation Near $3B
AI-driven Pathos AI secures a $237M Series E, led by Bristol Myers Squibb, to push forward its oncology portfolio and AI-enabled drug development platform.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com